AHSG | OmnibusX

Name	Number of supported studies	Average coverage
liver	3 studies	56% ± 28%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
liver	100%	87873.66	226 / 226	98%	3508.16	397 / 406
pancreas	88%	28.32	290 / 328	17%	0.52	31 / 178
ureter	0%	0	0 / 0	100%	1.11	1 / 1
brain	70%	7.80	1846 / 2642	15%	0.30	104 / 705
kidney	74%	8.60	66 / 89	4%	1.15	33 / 901
skin	59%	8.14	1059 / 1809	6%	0.76	28 / 472
lung	48%	6.38	278 / 578	14%	2.54	160 / 1155
esophagus	52%	6.95	756 / 1445	7%	3.72	13 / 183
spleen	57%	96.16	137 / 241	0%	0	0 / 0
stomach	45%	5.10	160 / 359	11%	1.76	32 / 286
uterus	45%	5.95	77 / 170	8%	0.33	35 / 459
peripheral blood	52%	66.49	484 / 929	0%	0	0 / 0
ovary	47%	4.30	84 / 180	4%	0.09	17 / 430
intestine	38%	5.23	363 / 966	10%	5.98	55 / 527
adrenal gland	47%	7.24	121 / 258	1%	0.08	2 / 230
prostate	42%	3.93	102 / 245	4%	0.13	22 / 502
heart	39%	5.98	340 / 861	0%	0	0 / 0
thymus	36%	5.07	237 / 653	3%	0.06	18 / 605
bladder	29%	1.57	6 / 21	11%	0.62	53 / 504
breast	34%	8.22	155 / 459	1%	0.19	9 / 1118
blood vessel	31%	4.79	410 / 1335	0%	0	0 / 0
adipose	28%	11.62	335 / 1204	0%	0	0 / 0
muscle	23%	2.24	183 / 803	0%	0	0 / 0
tonsil	0%	0	0 / 0	4%	0.11	2 / 45
lymph node	0%	0	0 / 0	3%	0.11	1 / 29
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
eye	0%	0	0 / 0	0%	0	0 / 80
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0

GO_0050766	Biological process	positive regulation of phagocytosis
GO_0006953	Biological process	acute-phase response
GO_0010951	Biological process	negative regulation of endopeptidase activity
GO_0030500	Biological process	regulation of bone mineralization
GO_0046627	Biological process	negative regulation of insulin receptor signaling pathway
GO_0050727	Biological process	regulation of inflammatory response
GO_0006907	Biological process	pinocytosis
GO_0030502	Biological process	negative regulation of bone mineralization
GO_0001501	Biological process	skeletal system development
GO_0001503	Biological process	ossification
GO_0005615	Cellular component	extracellular space
GO_0005576	Cellular component	extracellular region
GO_0070062	Cellular component	extracellular exosome
GO_0005794	Cellular component	Golgi apparatus
GO_0062023	Cellular component	collagen-containing extracellular matrix
GO_0031012	Cellular component	extracellular matrix
GO_0034774	Cellular component	secretory granule lumen
GO_0072562	Cellular component	blood microparticle
GO_0005788	Cellular component	endoplasmic reticulum lumen
GO_0031093	Cellular component	platelet alpha granule lumen
GO_0004869	Molecular function	cysteine-type endopeptidase inhibitor activity
GO_0004866	Molecular function	endopeptidase inhibitor activity
GO_0019210	Molecular function	kinase inhibitor activity

Gene name	AHSG
Protein name	Alpha-2-HS-glycoprotein (Alpha-2-Z-globulin) (Ba-alpha-2-glycoprotein) (Fetuin-A) [Cleaved into: Alpha-2-HS-glycoprotein chain A; Alpha-2-HS-glycoprotein chain B] Alpha-2-HS-glycoprotein (Fetuin-A)
Synonyms	FETUA PRO2743
Description	FUNCTION: Promotes endocytosis, possesses opsonic properties and influences the mineral phase of bone. Shows affinity for calcium and barium ions.
Accessions	ENST00000273784.5 ENST00000411641.7 P02765 C9JV77

AHSG report